These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6755071)

  • 21. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal conditions for simultaneous measurement of platelet aggregation and ATP secretion in canine whole blood.
    Jüttner C; Rodríguez M; Fragío C
    Res Vet Sci; 2000 Feb; 68(1):27-32. PubMed ID: 10684755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of desflurane on human platelet aggregation in vitro.
    Türkan H; Beyan C; Karabiyik L; Güner D; Kaptan K
    Int J Hematol; 2004 Jul; 80(1):91-3. PubMed ID: 15293576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.
    Jackson ML; Searcy GP; Olexson DW
    Can J Comp Med; 1985 Jul; 49(3):271-7. PubMed ID: 3930056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro.
    Boyd DG; Davis RB
    Thromb Res; 1988 May; 50(3):429-36. PubMed ID: 3394122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A note on the use of Quin2 in studying shear-induced platelet aggregation.
    Giorgio TD; Hellums JD
    Thromb Res; 1986 Feb; 41(3):353-9. PubMed ID: 3705013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation.
    Nimpf J; Wurm H; Kostner GM
    Atherosclerosis; 1987 Feb; 63(2-3):109-14. PubMed ID: 3827975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of platelet aggregation in ovine blood using a new impedance aggregometer.
    Baumgarten A; Wilhelmi M; Kalbantner K; Ganter M; Mischke R
    Vet Clin Pathol; 2010 Jun; 39(2):149-56. PubMed ID: 20003029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.
    Awidi A; Maqablah A; Dweik M; Bsoul N; Abu-Khader A
    Platelets; 2009 Aug; 20(5):297-301. PubMed ID: 19548178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Platelet membrane aggregation by platelet aggregation provoking substances].
    Watanabe K; Ando Y; Ikeda Y; Deguchi N
    Rinsho Byori; 1979; Suppl 40():257-67. PubMed ID: 551228
    [No Abstract]   [Full Text] [Related]  

  • 35. Ouabain affects platelet reactivity as measured in vitro.
    Prodouz KN; Poindexter BJ; Fratantoni JC
    Thromb Res; 1987 Apr; 46(2):337-46. PubMed ID: 3111004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effect of a microfibrillar collagen hemostat on platelets.
    McClure M; Duncan GD; Born GV; Robicsek F
    Haemostasis; 1987; 17(6):349-52. PubMed ID: 3428722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenine, an inhibitor of platelet aggregation, from the leaves of Cassia alata.
    Moriyama H; Iizuka T; Nagai M; Hoshi K
    Biol Pharm Bull; 2003 Sep; 26(9):1361-4. PubMed ID: 12951489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies on the energetics of platelet responses induced by different agonists.
    Verhoeven AJ; Mommersteeg ME; Akkerman JW
    Biochem J; 1986 Jun; 236(3):879-87. PubMed ID: 3098241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.